Board approves EGM corrigendum for name change to Tavexia Lifecare

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.0%1-day move

₹0.79

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————+0.0-2.5-1.3-3.8-2.5—————

Up moveDown movePending

AI summary

The board approved a corrigendum to its EGM notice after a BSE query on the in-principle name change application. Shareholders will vote on July 22, 2026 to rename the company to Tavexia Lifecare Limited. A CA certificate confirms SEBI Regulation 45(1) compliance. No change in business, share capital, management or shareholder rights. The rebranding signals expansion into manufacturing and trading of medicines.

Likely market impact

Cosmetic rebranding only. No change in capital or shareholder rights. Awaiting shareholder approval at EGM on July 22, 2026.